Wells Fargo’s Soleno Therapeutics SLNO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-20,751
| Closed | -$695K | – | 7569 |
|
|
2026
Q1 | $695K | Sell |
20,751
-31,892
| -61% | -$1.25M | ﹤0.01% | 3961 |
|
|
2025
Q4 | $2.44M | Buy |
52,643
+22,163
| +73% | +$1.22M | ﹤0.01% | 3280 |
|
|
2025
Q3 | $2.06M | Buy |
30,480
+9,320
| +44% | +$691K | ﹤0.01% | 3273 |
|
|
2025
Q2 | $1.77M | Buy |
21,160
+8,687
| +70% | +$650K | ﹤0.01% | 3299 |
|
|
2025
Q1 | $891K | Sell |
12,473
-74
| -0.6% | -$3.6K | ﹤0.01% | 3718 |
|
|
2024
Q4 | $564K | Buy |
12,547
+3,610
| +40% | +$187K | ﹤0.01% | 4091 |
|
|
2024
Q3 | $451K | Buy |
8,937
+1,291
| +17% | +$61.8K | ﹤0.01% | 4063 |
|
|
2024
Q2 | $312K | Buy |
7,646
+7,082
| +1,256% | +$300K | ﹤0.01% | 4216 |
|
|
2024
Q1 | $24.1K | Buy |
564
+449
| +390% | +$20.3K | ﹤0.01% | 5527 |
|
|
2023
Q4 | $4.63K | Buy |
115
+82
| +248% | +$2.33K | ﹤0.01% | 5968 |
|
|
2023
Q3 | $974 | Sell |
33
-7
| -18% | -$42 | ﹤0.01% | 6211 |
|
|
2023
Q2 | $172 | Buy |
40
+2
| +5% | +$9 | ﹤0.01% | 6743 |
|
|
2023
Q1 | $81 | Hold |
38
| – | – | ﹤0.01% | 6983 |
|
|
2022
Q4 | $75 | Buy |
38
+1
| +3% | +$1 | ﹤0.01% | 6870 |
|
|
2022
Q3 | $0 | Sell |
37
-6
| -14% | -$15 | ﹤0.01% | 7286 |
|
|
2022
Q2 | $0 | Buy |
43
+20
| +87% | +$55 | ﹤0.01% | 7417 |
|
|
2022
Q1 | $0 | Hold |
23
| – | – | ﹤0.01% | 7735 |
|
|
2021
Q4 | $0 | Hold |
23
| – | – | ﹤0.01% | 7746 |
|
|
2021
Q3 | $0 | Sell |
23
-1
| -4% | -$14 | ﹤0.01% | 7456 |
|
|
2021
Q2 | $0 | Sell |
24
-1,230
| -98% | -$20.8K | ﹤0.01% | 7379 |
|
|
2021
Q1 | $24K | Sell |
1,254
-4,408
| -78% | -$142K | ﹤0.01% | 6100 |
|
|
2020
Q4 | $163K | Sell |
5,662
-1,331
| -19% | -$38.4K | ﹤0.01% | 5166 |
|
|
2020
Q3 | $263K | Buy |
6,993
+3,241
| +86% | +$94.7K | ﹤0.01% | 4800 |
|
|
2020
Q2 | $125K | Buy |
3,752
+3,743
| +41,589% | +$162K | ﹤0.01% | 5125 |
|
|
2020
Q1 | $0 | Buy |
+9
| New | +$383 | ﹤0.01% | 6728 |
|
Wells Fargo's SLNO Position: Q2 2026 in Review
Wells Fargo sold out of Soleno Therapeutics (SLNO) in Q2 2026, closing a stake of 20,751 shares — an estimated $695K sold.
Wells Fargo first reported a position in SLNO in Q1 2020 and held it in 25 quarters. The position peaked at $2.44M in Q4 2025. 0 funds tracked by Wall St. Rank hold SLNO as of Q2 2026.
- Wells Fargo reported no remaining Soleno Therapeutics position as of Q2 2026 after selling out during the quarter.
- Wells Fargo sold 20,751 Soleno Therapeutics shares in Q2 2026, an estimated $695K.
- Wells Fargo first reported a position in Soleno Therapeutics in Q1 2020 and held it in 25 quarters.
- Wells Fargo's Soleno Therapeutics position peaked at $2.44M in Q4 2025.
- 0 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q2 2026.
Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.